Giapreza, a vasoconstrictor, increases blood pressure through increased aldosterone release La Jolla Pharmaceutical announced the availability of Giapreza (angiotesin II) injection for intravenous (IV ...

One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry. And regardless of whether the shock ...

Patients in distributive shock appear to have a lower risk for atrial fibrillation when vasopressin is added to catecholamine vasopressors, but its effect on other outcomes are mixed, according to a ...

Interim data found adding PHP/Hemoximer to vasopressor therapy increased number of deaths. A Phase III trial evaluating Curacyte’s Nitric Oxide (NO) scavenger pyridoxalated hemoglobin polyoxyethylene ...

Shock is the term used to describe the physiologic state when there is tissue hypoperfusion throughout multiple organs. [1] Decreased tissue perfusion leads to decreased tissue oxygen delivery. Early ...